Sanofi is one of the world's top producers of insulin, and the China market for treatment of the illness is huge: Some 140 ...

French pharma giant Sanofi will invest some 1 billion euros ($1.05 billion) to establish a new insulin production base in ...

Sanofi’s latest capital outlay in China will cover the development of a new insulin plant in the nation’s capital.

Sanofi just made its largest investment thus far in China. The company has committed just over $1 billion to build a new ...

The French pharma firm is seeking to increase insulin production in Beijing as trade tensions between the EU and China simmer ...

JPMorgan raised the firm’s price target on Sanofi (SNY) to EUR 105 from EUR 100 and keeps a Neutral rating on the shares.Don't Miss our Black ...

The divestiture of the Czech facility follows U.S.-based Novavax's licensing deal worth at least $1.2 billion with French ...

French drug major Sanofi plans to invest around 1 billion euros or about $1.05 billion to build a new insulin manufacturing base in ...

The China-based subsidiary of French pharma major Sanofi revealed it has signed a memorandum of cooperation with Beijing ...

Sanofi a leading global healthcare company invests ampeuro1 billion in Beijing for a new insulin plant creating jobs and bolstering China health ...

Sanofi has managed the daunting task faced by managers worldwide: hauling its employees back to the office with minimal fuss. That’s an impressive feat for a company that said last year it was ...